{
  "24642":{
    
  },
  "2477407":{
    
  },
  "248116":{
    "Figure_6.tif":{
      "a":{
        "descriptions":[
          "(panel a) from HepG2 cells after incubation with medium alone (controls), TNF-?? (10 ng/ml) and remifentanil (50 and 500 ng/ml) for 24 h or preincubation with remifentanil (50 and 500 ng/ml, 1 h incubation) followed by incubation with TNF-?? (10 ng/ml) for an additional 24 h (n???=???5) (The polyclonal antibody used is specific to recognize both the precursor procaspase-3 ???36 kDa and the mature active enzymes of 17???20 kDa following cleavage by upstream caspases) (C: control, R50: remifentanil 50 ng/ml, R500: remifentanil 500 ng/ml). Densitometric analysis of cleaved caspase protein levels "
        ],
        "rois":[
          
        ]
      },
      "b":{
        "descriptions":[
          "(panel b): the protein bands were analyzed and quantified densitometrically using Quantity One software from Bio-Rad. The relative levels of cleaved caspase 3 expression were normalized to actin and the results are expressed as arbitrary units and are means+/???SD for five independent experiments. Statistical analysis for cleaved caspase 3 levels was performed by one-way analysis of variance (ANOVA): # p???=???0.002. Afterwards, all groups were divided into subgroups and subsequent one-way ANOVA was performed in the subgroups (subgroup 1: control, TNF-??, R50 and R500 (p???=???0.006); subgroup 2: TNF-??, R50+TNF-?? and R500+TNF-??; p&???=???independent t-test R500+TNF- ?? vs. TNF-?? (p???=???0.02)."
        ],
        "rois":[
          {
            "x":150,
            "y":0,
            "x2":1427,
            "y2":821
          }
        ]
      },
      "B":{
        "descriptions":[
          
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":149,
            "y2":821
          }
        ]
      }
    }
  },
  "249142":{
    "Figure_1.tif":{
      "E":{
        "descriptions":[
          ", E: strong C-type; panels B"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1953,
            "y2":544
          }
        ]
      },
      "F":{
        "descriptions":[
          ", F: weak C-type; panels C"
        ],
        "rois":[
          {
            "x":0,
            "y":545,
            "x2":1953,
            "y2":2621
          }
        ]
      },
      "G":{
        "descriptions":[
          ", G: H-type; panels D"
        ],
        "rois":[
          {
            "x":0,
            "y":545,
            "x2":1953,
            "y2":2621
          }
        ]
      },
      "H":{
        "descriptions":[
          ", H: L-type. All the weak C type water dilutions series tested negative with Bio-Rad?? TeSeE??? SAP (notably, the optical densities were for all the three replicates of the 1???2 dilution just under the cut-off value), thereby, the odd ratio could not be calculated (Subfigure B)."
        ],
        "rois":[
          {
            "x":0,
            "y":545,
            "x2":1953,
            "y2":2621
          }
        ]
      }
    }
  },
  "249362":{
    
  },
  "24968":{
    
  },
  "250023":{
    "Figure_5.tif":{
      "I":{
        "descriptions":[
          ", I). MA-MADS5 was detected using anti-MA-MADS5 IgG coupled to FITC (green images) (Second row"
        ],
        "rois":[
          {
            "x":547,
            "y":7,
            "x2":1856,
            "y2":725
          }
        ]
      },
      "II":{
        "descriptions":[
          ", II). Nuclear localization of MA-MADS5 (yellow fluorescence) has been shown in the merged pictures of I and II of b to e respectively (third row, III). Fourth rows "
        ],
        "rois":[
          {
            "x":7,
            "y":741,
            "x2":2079,
            "y2":2705
          },
          {
            "x":630,
            "y":1754,
            "x2":1111,
            "y2":2229
          },
          {
            "x":640,
            "y":738,
            "x2":1107,
            "y2":1265
          },
          {
            "x":638,
            "y":1274,
            "x2":1112,
            "y2":1744
          },
          {
            "x":1606,
            "y":1274,
            "x2":2083,
            "y2":1744
          },
          {
            "x":1115,
            "y":1754,
            "x2":1600,
            "y2":2230
          },
          {
            "x":1119,
            "y":1272,
            "x2":1596,
            "y2":1748
          },
          {
            "x":1123,
            "y":732,
            "x2":1589,
            "y2":1265
          }
        ]
      },
      "IV":{
        "descriptions":[
          "(IV) of b???e indicate difference interference contrast pictures."
        ],
        "rois":[
          {
            "x":1612,
            "y":732,
            "x2":2078,
            "y2":1265
          }
        ]
      }
    }
  },
  "250178":{
    "Figure_2.tif":{
      "A":{
        "descriptions":[
          "(A) Study 1. The response score was the proportion of ???yes??? responses (range 0???1.0). Score 0 means that children did not regard the item as an agent, whereas score 1 means that children attributed the item with biological and psychological properties. BIO???=???Biological, PSY???=???Psychological, PER???=???Perceptual. "
        ],
        "rois":[
          {
            "x":8,
            "y":9,
            "x2":1891,
            "y2":903
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Study 2."
        ],
        "rois":[
          {
            "x":136,
            "y":1036,
            "x2":1658,
            "y2":1880
          }
        ]
      }
    }
  },
  "2510914":{
    
  },
  "25126":{
    
  },
  "25127":{
    
  },
  "25132":{
    
  },
  "25133":{
    
  },
  "25134":{
    
  },
  "25135":{
    
  },
  "25136":{
    
  },
  "252376":{
    "Figure_7.tif":{
      "B":{
        "descriptions":[
          "; B) fluorescent light and DIC"
        ],
        "rois":[
          {
            "x":9,
            "y":9,
            "x2":1774,
            "y2":1072
          }
        ]
      },
      "C":{
        "descriptions":[
          "; C) fluorescent light and polarized DIC and D) polarized DIC. White arrows indicate lysosomes visualized by DIC with overlapping glo-1::GFP signal, red ovals outline the shell of the embryo."
        ],
        "rois":[
          {
            "x":9,
            "y":1086,
            "x2":1774,
            "y2":2150
          }
        ]
      }
    }
  },
  "252975":{
    
  },
  "2534728":{
    
  },
  "2539":{
    
  },
  "254011":{
    
  },
  "2558260":{
    
  },
  "2575273":{
    
  },
  "2584144":{
    "Fig 3.tif":{
      "A":{
        "descriptions":[
          "(A) and SP-GNP "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1324,
            "y2":668
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B). SEM micrographs showed both blank GNP and SP-GNP were uniform in shape, and the dynamic light scattering demonstrated that both blank GNP and SP-GNP were uniform in size."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "2585329":{
    
  },
  "258745":{
    "Figure_3.tif":{
      "E":{
        "descriptions":[
          "(E) DNA sequence traces of DNA methylated with M.CbeI (top panel) or M.HaeIII (bottom panel). Differences in the G residue signals between M.HaeIII and M.CbeI pUC18 are shown in the middle panel."
        ],
        "rois":[
          {
            "x":55,
            "y":2024,
            "x2":1724,
            "y2":4279
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) The region of the C. bescii chromosome containing CbeI and M.CbeI. "
        ],
        "rois":[
          {
            "x":15,
            "y":15,
            "x2":1810,
            "y2":2011
          }
        ]
      },
      "M":{
        "descriptions":[
          ", M.CbeI methylated pDCW70 digested with purified CbeI"
        ],
        "rois":[
          {
            "x":31,
            "y":4381,
            "x2":1734,
            "y2":5161
          }
        ]
      },
      "MW":{
        "descriptions":[
          ", MW: 1 kb DNA ladder (NEB). "
        ],
        "rois":[
          
        ]
      },
      "B":{
        "descriptions":[
          "(B) Diagram of pDCW73 used to produce a His-tagged version of M.CbeI in E. coli. "
        ],
        "rois":[
          {
            "x":15,
            "y":15,
            "x2":1810,
            "y2":2011
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Purified M.CbeI displayed on a 10???20% Tris-HCl gradient gel (CriterionTM Precast Gel, Bio-Rad Laboratories, Hercules"
        ],
        "rois":[
          {
            "x":15,
            "y":15,
            "x2":1810,
            "y2":2011
          }
        ]
      },
      "CA":{
        "descriptions":[
          ", CA) stained with coomassie blue. lane 1: protein molecular weight standards (BioRad); lane 2: 15 ng of purified M.CbeI protein. "
        ],
        "rois":[
          {
            "x":31,
            "y":4381,
            "x2":1734,
            "y2":5161
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) lane 1, undigested unmethylated pDCW70; lane 2, undigested M.CbeI methylated pDCW70; lane 3, unmethylated pDCW70 digested with purified CbeI; lane 4"
        ],
        "rois":[
          {
            "x":55,
            "y":2024,
            "x2":1724,
            "y2":4279
          }
        ]
      }
    }
  },
  "259053":{
    
  },
  "259153":{
    
  },
  "2592253":{
    "Fig 1.TIF":{
      "E":{
        "descriptions":[
          "(E), oleoylethanolamide "
        ],
        "rois":[
          {
            "x":8,
            "y":1260,
            "x2":722,
            "y2":1760
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F), linoleoylethanolamide "
        ],
        "rois":[
          {
            "x":966,
            "y":1260,
            "x2":1613,
            "y2":1761
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A), anandamide "
        ],
        "rois":[
          {
            "x":5,
            "y":5,
            "x2":724,
            "y2":503
          }
        ]
      },
      "G":{
        "descriptions":[
          "(G), and palmitoylethanolamide "
        ],
        "rois":[
          {
            "x":938,
            "y":637,
            "x2":1610,
            "y2":1130
          },
          {
            "x":8,
            "y":1886,
            "x2":732,
            "y2":2387
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B), 2-linoleoylglycerol "
        ],
        "rois":[
          {
            "x":938,
            "y":5,
            "x2":1610,
            "y2":504
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C), docosahexaenoylethanolamide "
        ],
        "rois":[
          {
            "x":7,
            "y":636,
            "x2":739,
            "y2":1131
          }
        ]
      },
      "H":{
        "descriptions":[
          "(H) of subjects from each of the body mass index (BMI) sub-groups. The median is represented as a line within the box plot and the mean is represented as a + sign. Significant differences (p"
        ],
        "rois":[
          {
            "x":959,
            "y":1886,
            "x2":1627,
            "y2":2388
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D), 2-oleoylglycerol "
        ],
        "rois":[
          {
            "x":938,
            "y":637,
            "x2":1610,
            "y2":1130
          }
        ]
      }
    }
  },
  "259915":{
    "Figure_5.tif":{
      "E":{
        "descriptions":[
          "(E) Gelatin zymography and casein zymography were used to quantify MMP2, MMP9 and MMP7 activity, respectively, in cell-free conditioned media from OVCAR-3/CD157, OV-90/CD157 and the corresponding mock cells (left panel). Zymographic bands from all samples were quantified by densitometry (right panel). The enzyme activities are expressed as arbitrary units. Results are from one representative experiment performed in triplicate and are expressed as the mean ?? SD."
        ],
        "rois":[
          {
            "x":1545,
            "y":853,
            "x2":2085,
            "y2":1258
          },
          {
            "x":1207,
            "y":60,
            "x2":2044,
            "y2":767
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) Ovarian cancer cell migration through a mesothelial monolayer. Met-5A mesothelial cells were labeled with CellBrite??? Red and grown to confluence on fibronectin-coated coverslips. CFSE-stained tumor cells were plated onto the monolayer. After 6 h (OVCAR-3 cells) or 2.5 h (OV-90 cells) at 37??C, sample were fixed and analyzed using an Olympus FV300 laser scanning confocal microscope by sequential scanning of the XY planes recorded along the Z-axis (step size: 1.25 ??M). Series of confocal optical XY images were processed using a 3D reconstruction program (bioView3D software, Bio-Image Informatics, University of California, Santa Barbara"
        ],
        "rois":[
          {
            "x":1545,
            "y":1275,
            "x2":1943,
            "y2":1562
          },
          {
            "x":1012,
            "y":851,
            "x2":1460,
            "y2":1046
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Mesothelial layer integrity was verified by confocal microscopy analysis in CellBrite??? Red-labeled samples. Samples were analyzed with an Olympus FV300 laser scanning confocal microscope and by Nomarski differential interference contrast (DIC) optics. Scale bars : 50 ??M. "
        ],
        "rois":[
          {
            "x":1545,
            "y":853,
            "x2":2085,
            "y2":1258
          },
          {
            "x":1012,
            "y":851,
            "x2":1460,
            "y2":1046
          },
          {
            "x":90,
            "y":7,
            "x2":905,
            "y2":440
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Transmesothelial migration of OVCAR-3 and OV-90 cells. Where indicated, OVCAR-3/CD157, OV-90/CD157 and the corresponding mock cells were treated for 1 h with GM6001 (25 ??g/ml) before seeding onto Met-5A mesothelial cell monolayer. Results are expressed in terms of percent of transmigrated cells calculated as the ratio of cells that crossed the mesothelial layer to the total number of cells in the field. At least ten fields have been counted for each sample. Results are expressed as the mean ?? SEM of three independent experiments. P values were derived from analysis of variance (ANOVA) with Dunnett correction. **Pns, not significant. "
        ],
        "rois":[
          {
            "x":1545,
            "y":853,
            "x2":2085,
            "y2":1258
          },
          {
            "x":1012,
            "y":1047,
            "x2":1460,
            "y2":1144
          },
          {
            "x":35,
            "y":1054,
            "x2":1460,
            "y2":1566
          },
          {
            "x":555,
            "y":61,
            "x2":1161,
            "y2":1047
          },
          {
            "x":923,
            "y":512,
            "x2":1159,
            "y2":881
          },
          {
            "x":1012,
            "y":851,
            "x2":1460,
            "y2":1046
          },
          {
            "x":1207,
            "y":60,
            "x2":2044,
            "y2":767
          },
          {
            "x":7,
            "y":447,
            "x2":905,
            "y2":766
          }
        ]
      },
      "CA":{
        "descriptions":[
          ", CA). Top, orthogonal and bottom views are shown (scale bar: 50 ??M). "
        ],
        "rois":[
          
        ]
      },
      "D":{
        "descriptions":[
          "(D) sqRT-PCR expression of MMP2, MMP7, MMP9 and TIMP3 in engineered OVCAR-3 (left panel) and OV-90 cells (right panel). Densitometry quantifies the levels of expression of MMP compared with GADPH. "
        ],
        "rois":[
          {
            "x":1545,
            "y":853,
            "x2":2085,
            "y2":1258
          },
          {
            "x":74,
            "y":837,
            "x2":529,
            "y2":1047
          }
        ]
      }
    }
  },
  "2602135":{
    "Fig 5.tif":{
      "a":{
        "descriptions":[
          "(a) Viral titers in nasal washes of untreated infected controls (Ctr) and mice that received 6.0 mg/kg HB36.6 either 1 day before (Prophylaxis, Pro) or 1 day after (Therapeutic, Ther) infection with 10 MLD50 CA09 virus. Nasal washes collected on days 2, 4 and 6 post-infection were measured by determining the 50% tissue culture infectious dose (TCID50) (bars indicate mean viral titer ??SD, n = 18 mice per group, three replicate experiments). "
        ],
        "rois":[
          {
            "x":1391,
            "y":0,
            "x2":2992,
            "y2":1252
          }
        ]
      },
      "b":{
        "descriptions":[
          "(b) IHC staining of intracellular influenza NP (H1N1) of representative lung sections from uninfected (Na??ve) and untreated infected controls (Control) and HB36.6-treated mice (Prophylactic and Therapeutic) at 4 days post-infection with 10 MLD50 CA09 virus. Mouse lungs were not inflated with formalin and consequently resulted in lung collapse and a more hypercellular appearance in the uninfected control. Images selected show representative staining of influenza (NP) positive cells for each group. "
        ],
        "rois":[
          {
            "x":1391,
            "y":0,
            "x2":2992,
            "y2":1252
          }
        ]
      },
      "c":{
        "descriptions":[
          "(c) Quantification of influenza positive cells in lung tissues was performed by measuring the area of positive staining compared to the total tissue on the slide (uniform random sampling of 50% lung tissue). "
        ],
        "rois":[
          {
            "x":0,
            "y":1193,
            "x2":1315,
            "y2":2241
          }
        ]
      },
      "d":{
        "descriptions":[
          "(d) Inflammatory cytokines were assayed by Bio-Plex using supernatants from lung homogenates obtained from BALB/c mice on day 2 following infection with 10 MLD50 CA09 virus (n = 8 mice per group). The fold change over na??ve-uninfected mice is shown. For a, c and d, significant differences between the Pro and Ther groups to the Ctr group are shown: *P "
        ],
        "rois":[
          {
            "x":0,
            "y":17,
            "x2":2954,
            "y2":2244
          }
        ]
      }
    }
  },
  "2602138":{
    
  },
  "2602561":{
    
  },
  "260341":{
    "Figure_2.tif":{
      "A":{
        "descriptions":[
          "(A) Western blot analysis of expression of E-cadherin and vimentin in SW620-mock and SW620-shRNA-SOX2 cells. GAPDH was used as a loading control. The right panel showed the right panel quantified by the Quantity One software (Bio-Rad). GAPDH was used for normalization. "
        ],
        "rois":[
          {
            "x":16,
            "y":16,
            "x2":4116,
            "y2":762
          },
          {
            "x":3187,
            "y":216,
            "x2":3647,
            "y2":762
          },
          {
            "x":2723,
            "y":216,
            "x2":3183,
            "y2":762
          },
          {
            "x":17,
            "y":871,
            "x2":1671,
            "y2":2159
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Immunofluorescence images of SW620-mock and SW620-shRNA-SOX2 cells stained with antibodies against E-cadherin, vimentin and SOX2. Secondary antibody was conjugated with FITC and Cy3. Cell nuclei were stained with Hoechest 33258. "
        ],
        "rois":[
          {
            "x":989,
            "y":36,
            "x2":1942,
            "y2":764
          },
          {
            "x":1861,
            "y":212,
            "x2":2719,
            "y2":762
          },
          {
            "x":1780,
            "y":769,
            "x2":4118,
            "y2":2277
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Semi-quantitative RT-PCR analysis of EMT-related regulatory factors. GAPDH was used as a loading control."
        ],
        "rois":[
          {
            "x":989,
            "y":36,
            "x2":1942,
            "y2":764
          }
        ]
      }
    }
  },
  "260471":{
    "Figure_3.tif":{
      "E":{
        "descriptions":[
          "(E) Quantitative real time PCR analysis of c-Myc gene in SW620-mock and SW620-shRNA-SOX2 cells. "
        ],
        "rois":[
          {
            "x":2137,
            "y":1470,
            "x2":2765,
            "y2":2119
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F) Quantitative real time PCR analysis of cyclin D1 expression in SW620-mock and SW620-shRNA-SOX2 cells."
        ],
        "rois":[
          {
            "x":2262,
            "y":2124,
            "x2":2586,
            "y2":2278
          },
          {
            "x":3402,
            "y":1959,
            "x2":4019,
            "y2":2233
          },
          {
            "x":2137,
            "y":1470,
            "x2":2765,
            "y2":2119
          },
          {
            "x":1478,
            "y":1629,
            "x2":1987,
            "y2":2207
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) Immunofluorescence images of SW620-mock and SW620-shRNA-SOX2 cells stained with anti-beta-catenin antibody. Secondary antibody was conjugated with CY3. Cell nuclei were stained with Hoechest 33258. The top 6 panels are in 100?? magnification and the lower 6 panels are in 400?? magnification. "
        ],
        "rois":[
          {
            "x":2813,
            "y":1494,
            "x2":3237,
            "y2":2276
          },
          {
            "x":959,
            "y":1141,
            "x2":1465,
            "y2":1616
          },
          {
            "x":1478,
            "y":637,
            "x2":2145,
            "y2":1127
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Western blot analysis of beta-catenin expression using cytoplasmic and nuclear fractions of SW620-mock and SW620-shRNA-SOX2 cells. Alpha-tubulin and Lamin B were used as loading controls for the cytoplasmic and nuclear fractions respectively. The right panel showed the band intensities (left panel) quantified by the Quantity One software (Bio-Rad). "
        ],
        "rois":[
          {
            "x":71,
            "y":1629,
            "x2":943,
            "y2":2243
          },
          {
            "x":114,
            "y":1141,
            "x2":943,
            "y2":1616
          },
          {
            "x":3480,
            "y":1011,
            "x2":4078,
            "y2":1682
          },
          {
            "x":3361,
            "y":1775,
            "x2":4019,
            "y2":1926
          },
          {
            "x":1478,
            "y":63,
            "x2":2152,
            "y2":608
          },
          {
            "x":15,
            "y":63,
            "x2":1465,
            "y2":608
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) LEF1/TCF1-luciferase activity in SW620-mock and SW620-shRNA-SOX2 cells. "
        ],
        "rois":[
          {
            "x":71,
            "y":1629,
            "x2":943,
            "y2":2243
          },
          {
            "x":959,
            "y":1627,
            "x2":1467,
            "y2":2200
          },
          {
            "x":3496,
            "y":20,
            "x2":4114,
            "y2":894
          },
          {
            "x":63,
            "y":637,
            "x2":1465,
            "y2":1127
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) Quantitative real time PCR (upper panel) and western blot (lower panel) analyses of LEF1 in SW620-mock and SW620-shRNA-SOX2 cells. GAPDH was used as a loading control. "
        ],
        "rois":[
          {
            "x":959,
            "y":1627,
            "x2":1467,
            "y2":2200
          },
          {
            "x":2107,
            "y":180,
            "x2":3380,
            "y2":1418
          },
          {
            "x":1480,
            "y":1141,
            "x2":1987,
            "y2":1616
          }
        ]
      }
    }
  },
  "262329":{
    
  },
  "2623850":{
    "Fig 3.tif":{
      "A":{
        "descriptions":[
          ". A) Cullin 1"
        ],
        "rois":[
          {
            "x":44,
            "y":433,
            "x2":504,
            "y2":498
          },
          {
            "x":19,
            "y":5,
            "x2":589,
            "y2":419
          }
        ]
      },
      "B":{
        "descriptions":[
          "; B) SKP1 (antibody 4E11)"
        ],
        "rois":[
          {
            "x":577,
            "y":63,
            "x2":1110,
            "y2":401
          }
        ]
      },
      "C":{
        "descriptions":[
          "; C) RBX1. The data were processed using Quantity One software (Bio-Rad). 100% represents the sum of the trace quantities of all bands; relative abundance (y-axis) represents the percentage of each band. Bars show mean ?? S.D. a,bValues with different superscripts indicate statistical significance (P"
        ],
        "rois":[
          {
            "x":607,
            "y":409,
            "x2":1080,
            "y2":506
          },
          {
            "x":10,
            "y":542,
            "x2":985,
            "y2":1055
          }
        ]
      }
    }
  },
  "262477":{
    "Figure_4.tif":{
      "A":{
        "descriptions":[
          "(A) CHRF-288-11 cells or "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1127,
            "y2":2550
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) HeLa cells were serum starved for 12 h and incubated with W7 (150 ??M) for 10 min followed by addition of thrombin to CHRF-288-11 cells and EGF to HeLa cells for 1 min or 3 min. At the end of the incubation cells were lysed using RIPA buffer. After centrifugation, 60 ??l of the supernatant was suspended in 20 ??l 4X Laemmli's sample buffer to determine level of endogenous Rac1 in various samples by western blotting. The rest of the supernatant was incubated with GST-PAK1 for 2 h at 4??C. After incubation, the beads were washed three times with Rac1 washing buffer. The final bead pellet was suspended in 30 ??l of Laemmli's sample buffer and heated at 100??C for 5 min. Western blotting was performed using mouse anti-Rac1 antibody. Quantification (adjusted for endogenous level of Rac1) was carried out using Bio-Rad ???quantity one??? program and *p"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1127,
            "y2":2550
          }
        ]
      }
    }
  },
  "262564":{
    
  },
  "262776":{
    
  },
  "2634010":{
    "Fig 8.tif":{
      "E":{
        "descriptions":[
          "(E) conditions for ND. See Table 1 for parameter descriptions."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2999,
            "y2":1227
          }
        ]
      },
      "DF":{
        "descriptions":[
          "(DF) or endemic "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2999,
            "y2":1227
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) homogeneous and ",
          "(A), the root node rule is the duration of the acute infectious stage (D?) less than 11.08 days; the subset of simulations satisfying this rule partitioned to the left daughter node and consecutively down the nodes. The terminal nodes represent disease-free "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2999,
            "y2":1227
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) age-structured populations of white-winged parakeets. The rule for data partitioning is on top of each node. For example, in panel "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2999,
            "y2":1227
          }
        ]
      },
      "ND":{
        "descriptions":[
          "(ND) in "
        ],
        "rois":[
          
        ]
      }
    }
  },
  "263416":{
    "Figure_6.tif":{
      "E":{
        "descriptions":[
          ", E. coli cells were removed by centrifugation, supernatants were analyzed with SDS-PAGE (Panel A and Panel B)"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1469,
            "y2":1146
          }
        ]
      },
      "A":{
        "descriptions":[
          ". Panel A: Lane 1, YebF-ACP expressed extracellularly; Lane 2, YebF-ACP expressed extracellularly and coexpressed with cytosolic modification enzyme AcpS; Lane 3, YebF-ACP expressed extracellularly and coexpressed with cytosolic modification enzyme AcpS, and with addition of 1 mM sodium azide in culture medium"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1469,
            "y2":1146
          }
        ]
      },
      "B":{
        "descriptions":[
          ". Panel B: Lane 1, YebF-BCCP87 expressed extracellularly; Lane 2, YebF-BCCP87 expressed extracellularly and coexpressed with cytosolic modification enzyme BirA; Lane 3, YebF-BCCP87 expressed extracellularly and coexpressed with cytosolic modification enzyme BirA, and with addition of 1 mM sodium azide in culture medium. Panel C, Target proteins was quantified by Quantity Tools (Image Lab??? software, Version 2.0, BIO-RAD). The densitometric value of the band of YebF-ACP or YebF-BCCP87 expressed extracellularly was set to be 1. Each bar represented the mean ?? standard error, three replicates. Open bars: fusion proteins expressed extracellularly; Filled bars: fusion proteins expressed extracellularly and coexpressed with corresponding cytosolic modification enzymes; Hatched bars: fusion proteins expressed extracellularly and coexpressed with corresponding cytosolic modification enzymes, and with addition of 1 mM sodium azide in culture medium."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1469,
            "y2":1146
          }
        ]
      }
    }
  },
  "2644375":{
    "Fig 2.tif":{
      "A":{
        "descriptions":[
          "(A) Bioluminescence images of rat at day 1, 2, 7, 14, 28, 35 and 64 after a subconjunctival or intravenous injection of Ad-Luci (1x1010 GC/eye). "
        ],
        "rois":[
          {
            "x":4,
            "y":5,
            "x2":1053,
            "y2":1053
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Luciferase activity was measured in unit of photons by bioluminescence analysis. Data are presented as the means ?? SEM (n = 5)."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "266566":{
    
  },
  "2667754":{
    
  },
  "2667772":{
    "Fig 4.tif":{
      "CL":{
        "descriptions":[
          "(CL) and drag coefficients "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1639,
            "y2":1363
          }
        ]
      },
      "CD":{
        "descriptions":[
          "(CD) for the bio-realistic (bio) and simple wings against angle of attack (????). Both wings share very similar performance trends. The lift is noted to plateau at about 15??. The flat wing presents a higher lift value regardless of Reynolds number. At large angles of attack the drag values match very well between the two wings due to the large degree of separation which minimizes the effects of the corrugations."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1639,
            "y2":1363
          }
        ]
      }
    }
  },
  "2667781":{
    
  },
  "2667793":{
    
  },
  "2667805":{
    
  },
  "2667820":{
    
  },
  "2667832":{
    
  },
  "2667847":{
    
  },
  "266945":{
    "Figure_2.tif":{
      "E":{
        "descriptions":[
          "(E) Graph showing proportion of ??-gal expressing cells in specific regions of cultured cerebellum slices. Statistical comparisons were made between each of the treatment groups and the DMSO control group for each region by a Student's T-test. "
        ],
        "rois":[
          {
            "x":7,
            "y":388,
            "x2":339,
            "y2":728
          },
          {
            "x":385,
            "y":388,
            "x2":1087,
            "y2":809
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F) qRT-PCR analysis of Axin2 expression in cultured slices. Each treated group was compared to the DMSO control group by a Student's T-test. For each test, n???=???3, error bars???=???SEM, *???=???p"
        ],
        "rois":[
          {
            "x":1101,
            "y":389,
            "x2":1668,
            "y2":807
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A), 20 ??M BIO "
        ],
        "rois":[
          {
            "x":124,
            "y":8,
            "x2":602,
            "y2":365
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) or 50 ??M CHIR "
        ],
        "rois":[
          {
            "x":7,
            "y":388,
            "x2":339,
            "y2":728
          },
          {
            "x":612,
            "y":8,
            "x2":1091,
            "y2":366
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C). "
        ],
        "rois":[
          {
            "x":7,
            "y":388,
            "x2":339,
            "y2":728
          },
          {
            "x":1100,
            "y":7,
            "x2":1578,
            "y2":364
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) Schematic drawing of cerebellum slice indicating regions used for quantitation. "
        ],
        "rois":[
          {
            "x":7,
            "y":388,
            "x2":339,
            "y2":728
          },
          {
            "x":385,
            "y":388,
            "x2":1087,
            "y2":809
          }
        ]
      }
    }
  },
  "267032":{
    "Figure_3.tif":{
      "E":{
        "descriptions":[
          "(B,E,H) OR 50 ??M CHIR "
        ],
        "rois":[
          {
            "x":374,
            "y":2190,
            "x2":983,
            "y2":2649
          },
          {
            "x":768,
            "y":439,
            "x2":1285,
            "y2":826
          },
          {
            "x":241,
            "y":1226,
            "x2":761,
            "y2":1615
          },
          {
            "x":242,
            "y":7,
            "x2":760,
            "y2":432
          }
        ]
      },
      "N":{
        "descriptions":[
          "(N,O) qRT-PCR analysis of expression of Sox9 ",
          "(N) and Gfap "
        ],
        "rois":[
          {
            "x":763,
            "y":1695,
            "x2":1402,
            "y2":2147
          },
          {
            "x":1290,
            "y":6,
            "x2":1808,
            "y2":432
          },
          {
            "x":242,
            "y":7,
            "x2":760,
            "y2":432
          }
        ]
      },
      "F":{
        "descriptions":[
          "(C,F,I) and analysed by immunohistochemistry for the expression of Sox9 (A???C), GFAP (D???F), Pax2 (G???I) and Calbindin (J???L). "
        ],
        "rois":[
          {
            "x":374,
            "y":2190,
            "x2":983,
            "y2":2649
          },
          {
            "x":1292,
            "y":438,
            "x2":1812,
            "y2":1614
          },
          {
            "x":241,
            "y":1226,
            "x2":761,
            "y2":1615
          },
          {
            "x":242,
            "y":7,
            "x2":760,
            "y2":432
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A,D,G), 20 ??M BIO "
        ],
        "rois":[
          {
            "x":769,
            "y":834,
            "x2":1286,
            "y2":1221
          }
        ]
      },
      "M":{
        "descriptions":[
          "(M) Graph showing the proportion of Sox9+ cells in specific regions of cultured slices. "
        ],
        "rois":[
          {
            "x":6,
            "y":1695,
            "x2":720,
            "y2":2149
          },
          {
            "x":1290,
            "y":6,
            "x2":1808,
            "y2":432
          },
          {
            "x":242,
            "y":7,
            "x2":760,
            "y2":432
          }
        ]
      },
      "I":{
        "descriptions":[
          "(C,F,I) and analysed by immunohistochemistry for the expression of Sox9 (A???C), GFAP (D???F), Pax2 (G???I) and Calbindin (J???L). "
        ],
        "rois":[
          {
            "x":374,
            "y":2190,
            "x2":983,
            "y2":2649
          },
          {
            "x":1290,
            "y":6,
            "x2":1808,
            "y2":432
          },
          {
            "x":768,
            "y":1226,
            "x2":1287,
            "y2":1615
          },
          {
            "x":242,
            "y":7,
            "x2":760,
            "y2":432
          }
        ]
      },
      "G":{
        "descriptions":[
          "(A,D,G), 20 ??M BIO "
        ],
        "rois":[
          {
            "x":1436,
            "y":1692,
            "x2":2057,
            "y2":2148
          },
          {
            "x":374,
            "y":2190,
            "x2":983,
            "y2":2649
          },
          {
            "x":1290,
            "y":6,
            "x2":1808,
            "y2":432
          },
          {
            "x":241,
            "y":1226,
            "x2":761,
            "y2":1615
          },
          {
            "x":242,
            "y":7,
            "x2":760,
            "y2":432
          }
        ]
      },
      "Q":{
        "descriptions":[
          "(Q) Graph showing the proportion of Calbindin+ cells in the dorsal region of each slice. In all cases, direct comparisons were made by comparing each treatment group with the relevant DMSO control with a Student's T-test. For each test, n???=???3, error bars???=???SEM, *???=???p"
        ],
        "rois":[
          {
            "x":1104,
            "y":2189,
            "x2":1733,
            "y2":2653
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B,E,H) OR 50 ??M CHIR "
        ],
        "rois":[
          {
            "x":374,
            "y":2190,
            "x2":983,
            "y2":2649
          },
          {
            "x":767,
            "y":8,
            "x2":1284,
            "y2":433
          }
        ]
      },
      "P":{
        "descriptions":[
          "(P) Graph showing the proportion of Pax2+ cells in specific regions of cultured slices. "
        ],
        "rois":[
          {
            "x":1290,
            "y":6,
            "x2":1808,
            "y2":432
          },
          {
            "x":244,
            "y":833,
            "x2":761,
            "y2":1220
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C,F,I) and analysed by immunohistochemistry for the expression of Sox9 (A???C), GFAP (D???F), Pax2 (G???I) and Calbindin (J???L). "
        ],
        "rois":[
          {
            "x":374,
            "y":2190,
            "x2":983,
            "y2":2649
          },
          {
            "x":244,
            "y":833,
            "x2":761,
            "y2":1220
          },
          {
            "x":241,
            "y":1226,
            "x2":761,
            "y2":1615
          }
        ]
      },
      "H":{
        "descriptions":[
          "(B,E,H) OR 50 ??M CHIR "
        ],
        "rois":[
          {
            "x":374,
            "y":2190,
            "x2":983,
            "y2":2649
          },
          {
            "x":1290,
            "y":6,
            "x2":1808,
            "y2":432
          },
          {
            "x":769,
            "y":834,
            "x2":1286,
            "y2":1221
          },
          {
            "x":241,
            "y":1226,
            "x2":761,
            "y2":1615
          },
          {
            "x":242,
            "y":7,
            "x2":760,
            "y2":432
          }
        ]
      },
      "O":{
        "descriptions":[
          "(N,O) qRT-PCR analysis of expression of Sox9 ",
          "(O) expression, relative to EIF4A2 control. "
        ],
        "rois":[
          {
            "x":1104,
            "y":2189,
            "x2":1733,
            "y2":2653
          },
          {
            "x":1290,
            "y":6,
            "x2":1808,
            "y2":432
          }
        ]
      },
      "D":{
        "descriptions":[
          "(A,D,G), 20 ??M BIO "
        ],
        "rois":[
          {
            "x":374,
            "y":2190,
            "x2":983,
            "y2":2649
          },
          {
            "x":242,
            "y":440,
            "x2":760,
            "y2":827
          },
          {
            "x":241,
            "y":1226,
            "x2":761,
            "y2":1615
          }
        ]
      }
    }
  },
  "267164":{
    "Figure_4.tif":{
      "E":{
        "descriptions":[
          "(B,E) or 50 ??M CHIR "
        ],
        "rois":[
          {
            "x":973,
            "y":406,
            "x2":1447,
            "y2":761
          },
          {
            "x":490,
            "y":406,
            "x2":964,
            "y2":762
          }
        ]
      },
      "F":{
        "descriptions":[
          "(C,F) and analysed by immunohistochemistry for the retention of a BrdU label administered two hours prior to fixation (A???C) or apoptotic marker Caspase3 (D???F). "
        ],
        "rois":[
          {
            "x":973,
            "y":406,
            "x2":1447,
            "y2":761
          },
          {
            "x":490,
            "y":406,
            "x2":964,
            "y2":762
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A,D), 20 ??M BIO "
        ],
        "rois":[
          {
            "x":7,
            "y":8,
            "x2":481,
            "y2":399
          }
        ]
      },
      "G":{
        "descriptions":[
          "(G) Graph showing proportion of BrdU+ cells in specific areas of cultured slices. "
        ],
        "rois":[
          {
            "x":45,
            "y":809,
            "x2":757,
            "y2":1222
          },
          {
            "x":490,
            "y":406,
            "x2":964,
            "y2":762
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B,E) or 50 ??M CHIR "
        ],
        "rois":[
          {
            "x":489,
            "y":6,
            "x2":963,
            "y2":399
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C,F) and analysed by immunohistochemistry for the retention of a BrdU label administered two hours prior to fixation (A???C) or apoptotic marker Caspase3 (D???F). "
        ],
        "rois":[
          {
            "x":974,
            "y":8,
            "x2":1449,
            "y2":399
          },
          {
            "x":490,
            "y":406,
            "x2":964,
            "y2":762
          }
        ]
      },
      "H":{
        "descriptions":[
          "(H) Graph showing density of Caspase3 labelled cells per unit area in specific regions of cultured slices. In all cases statistical comparisons were made by comparing each treatment group with the appropriate DMSO control using a Student's T-test. For each test, n???=???3, error bars???=???SEM, *???=???p"
        ],
        "rois":[
          {
            "x":809,
            "y":811,
            "x2":1387,
            "y2":1219
          }
        ]
      },
      "D":{
        "descriptions":[
          "(A,D), 20 ??M BIO "
        ],
        "rois":[
          {
            "x":7,
            "y":408,
            "x2":481,
            "y2":763
          },
          {
            "x":490,
            "y":406,
            "x2":964,
            "y2":762
          }
        ]
      }
    }
  },
  "267271":{
    "Figure_1.tif":{
      "A":{
        "descriptions":[
          "(A) Layout of biotin IgM indirect EIA (Bio-EIA). "
        ],
        "rois":[
          {
            "x":8,
            "y":8,
            "x2":344,
            "y2":648
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) The distribution of EIA absorbance values of 612 adults??? serum samples of Group 1 and Group 2. Five-pointed star: HRP conjugates."
        ],
        "rois":[
          {
            "x":359,
            "y":8,
            "x2":1000,
            "y2":703
          }
        ]
      }
    }
  },
  "267520":{
    "Figure_4.tif":{
      "I":{
        "descriptions":[
          "(I) Biotinylated MCVLPs (at concentrations of 100 ng, 10 ng, 5 ng, 1 ng/100 ??L), "
        ],
        "rois":[
          {
            "x":8,
            "y":8,
            "x2":1487,
            "y2":1413
          }
        ]
      },
      "II":{
        "descriptions":[
          "(II) Biotinylated BSA (at concentrations of 20 ??g, 10 ??g, 1 ??g, 100 ng/100 ??L) or (III) Soluble biotin (at concentrations of 20 ??g, 10 ??g, 1 ??g, 100 ng/100 ??L). The reactivities were plotted in boxplot. Five-pointed star: HRP conjugates. P: positive group comprising nine Bio-IgM positive sera. N: negative group comprising nine Bio-IgM-negative sera."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "267602":{
    "Figure_5.tif":{
      "A":{
        "descriptions":[
          "(A) In inhouse MCV IgM EIA, biotinylated MCV VLPs (10 ng/100 ??L) were mixed with increasing concentrations of either unbiotinylated MCV VLPs or soluble biotin and added onto the ??-capture plates (100 ??L/well). "
        ],
        "rois":[
          {
            "x":9,
            "y":12,
            "x2":499,
            "y2":186
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) The upper figures show two serum samples positive for biotin IgM; the lower figures show two serum samples positive for MCV IgM. (C and D) In Bio-EIA, four samples positive for biotin IgM were coincubated with avidin and applied to the assay. Five-pointed star: HRP conjugates."
        ],
        "rois":[
          {
            "x":533,
            "y":9,
            "x2":1615,
            "y2":2271
          },
          {
            "x":9,
            "y":12,
            "x2":499,
            "y2":186
          },
          {
            "x":23,
            "y":1324,
            "x2":407,
            "y2":2252
          },
          {
            "x":41,
            "y":212,
            "x2":459,
            "y2":1085
          }
        ]
      }
    }
  },
  "267712":{
    
  },
  "267791":{
    
  },
  "2680261":{
    
  },
  "270130":{
    "Figure_2.tif":{
      "A":{
        "descriptions":[
          "(A) PCR for detecting TG mice. Two pairs of primers were used to amplify the 489 bp and 282 bp inserts. M, 100 bp DNA ladder; 10???37, TG founders; N, genomic DNA from WT mouse as a negative control; P, circular BAC DNA as a positive control. "
        ],
        "rois":[
          {
            "x":9,
            "y":7,
            "x2":941,
            "y2":182
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Southern blot analysis of integrated pFSH transgenes. Purified genomic DNA (10 ??g) from each TG founder was digested by BamHI overnight at 37??C and analyzed by Southern blotting using probes specific for pFSH?? and pFSH??. 10???37, TG founders; P, porcine genomic DNA as positive control; N, genomic DNA from a WT mouse as a negative control. Band intensity was quantified by densitometry using Quantity-One software (Bio-Rad). (C???D) The two ends of both the BAC412H8 and BAC183O11 transgenes were amplified separately from TG mouse genomic DNA using 5???- or 3???-specific primers."
        ],
        "rois":[
          {
            "x":7,
            "y":230,
            "x2":2059,
            "y2":1258
          },
          {
            "x":1058,
            "y":7,
            "x2":1996,
            "y2":180
          }
        ]
      }
    }
  },
  "271267":{
    "Figure_3.tif":{
      "kd":{
        "descriptions":[
          "(kd) rate constants. "
        ],
        "rois":[
          {
            "x":20,
            "y":1841,
            "x2":990,
            "y2":2557
          }
        ]
      },
      "ka":{
        "descriptions":[
          "(ka) and dissociation "
        ],
        "rois":[
          {
            "x":20,
            "y":1841,
            "x2":990,
            "y2":2557
          }
        ]
      },
      "a":{
        "descriptions":[
          "(a) Equilibrium dissociation constant (KD) for P12/P41 interaction. Serial dilutions of recP41-Cd4d3/4-6H were injected through flow cells containing Cd4d3/4 (as a reference) and recP12-Cd4d3/4-bio captured on a streptavidin-coated sensor chip until equilibrium had been reached (see inset). Reference-subtracted binding data were plotted as a binding curve and an equilibrium dissociation constant calculated using non-linear regression fitting of a simple Langmuir binding isotherm to the data (solid line). "
        ],
        "rois":[
          {
            "x":102,
            "y":9,
            "x2":1717,
            "y2":905
          }
        ]
      },
      "b":{
        "descriptions":[
          "(b) Kinetic data for the P12/P41 interaction. Serial two-fold dilutions of 3.6 ??M purified recP41-Cd4d3/4-6H were injected at high flow rates (100 ??L min???1) over recP12 and a reference flow cell. Sensorgrams showed excellent fits to a simple 1???1 binding model (shown in red) and were used to derive association "
        ],
        "rois":[
          {
            "x":9,
            "y":981,
            "x2":982,
            "y2":1797
          }
        ]
      },
      "c":{
        "descriptions":[
          "(c, d) P12 and P41 do not interact homophilically. ",
          "(c) Injection (solid bar) of purified 2.5 ??M recP12-CD4d3/4-6H over recP41-Cd4d3/4-bio (blue line) and recP12-Cd4d3/4-bio (red dotted line) immobilised on a streptavidin-coated sensor chip. The reciprocal experiment using purified P41 is shown in "
        ],
        "rois":[
          {
            "x":1081,
            "y":1074,
            "x2":1977,
            "y2":1793
          }
        ]
      },
      "d":{
        "descriptions":[
          "(c, d) P12 and P41 do not interact homophilically. ",
          "(d)."
        ],
        "rois":[
          {
            "x":1086,
            "y":1841,
            "x2":1972,
            "y2":2557
          }
        ]
      }
    }
  },
  "272030":{
    
  },
  "272043":{
    "Figure_8.tif":{
      "A":{
        "descriptions":[
          ". A. Colonies (+) were counted using a Bio-Rad ChemiDoc XRS + imager in biological triplicate"
        ],
        "rois":[
          {
            "x":9,
            "y":10,
            "x2":1527,
            "y2":912
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B. Representative wells showing IPTG and ICI 182780 and vehicle (control) treated colonies at week 4"
        ],
        "rois":[
          {
            "x":73,
            "y":984,
            "x2":1851,
            "y2":2204
          }
        ]
      },
      "C":{
        "descriptions":[
          ". C. IPTG treated cells at week 12."
        ],
        "rois":[
          {
            "x":98,
            "y":2242,
            "x2":1866,
            "y2":2626
          }
        ]
      }
    }
  },
  "272427":{
    
  },
  "2730421":{
    
  },
  "2732860":{
    "Fig 1.tif":{
      "A":{
        "descriptions":[
          "A. Scanning electron microscopy (SEM) images of COOH-functionalized Au-labeled Thiol-Carbon derived bionanofluids, at two different magnifications. Au particles have defined spherical structures, highlighted by the arrowhead"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2249,
            "y2":1891
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B. EDC-NHS coupling chemistry to attach bio-affinity molecules, whether antibody or protein/mitogen to the Thiol-PEG-CNT. PEGylation of the Thiol-CNT is described in the Materials and Methods."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "278346":{
    "Figure_1.tif":{
      "a":{
        "descriptions":[
          "(a) Cell viability quantified by Syto60 after 72 hours of AZ-628, CI-1040 or BAY61-3606 treatment in HCT-116 (K-RASG13D/+, red) or HKe-3 (K-RAS???/+, blue) cell lines. Relative cell viability was normalized to DMSO vehicle treated control for each cell line. Error bars represent SEM for 3 independent experiments. Cells expressing mutant K-RAS were relatively sensitive to AZ-628 and BAY61-3606, but not CI-1040. "
        ],
        "rois":[
          {
            "x":10,
            "y":7,
            "x2":2050,
            "y2":551
          }
        ]
      },
      "b":{
        "descriptions":[
          "(b) Cell cycle profiles, as determined by propidium iodide staining, of colorectal cancer cells with mutant B-RAF (HT-29) treated with CI-1040 or mutant K-RAS (DLD-1) treated with BAY61-3606. While inhibition of MEK induces G1 arrest in HT-29 cells, as evidenced by the loss of the 4N peak, BAY61-3606 did not appear to alter the profile of DLD-1 cells. "
        ],
        "rois":[
          {
            "x":11,
            "y":609,
            "x2":1213,
            "y2":1181
          }
        ]
      },
      "c":{
        "descriptions":[
          "(c) Cell viability of colorectal cancer cells expressing mutant B-RAF (V600E) after 72 hours of treatment with BAY61-3606 and/or CI-1040. Cells expressing mutant B-RAF (HT-29 ??? solid outline and RKO ??? dotted outline) were sensitive to both BAY61-3606 and CI-1040 and these two inhibitors cooperated to produce an enhanced response. "
        ],
        "rois":[
          {
            "x":1357,
            "y":609,
            "x2":2035,
            "y2":1196
          }
        ]
      },
      "D":{
        "descriptions":[
          
        ],
        "rois":[
          {
            "x":742,
            "y":1253,
            "x2":1813,
            "y2":1789
          }
        ]
      },
      "d":{
        "descriptions":[
          "(d) Phospho-MEK1 (Ser217/Ser221) and phospho-ERK1/2 (Thr202/Tyr204, Thr185/Tyr187) levels in K-RAS wild-type and mutant cells after 45 minute exposure to 1 ??M AZ-628, 1 ??M BAY61-3606, or vehicle control. Signals were measured using Bio-Plex assays. Relative signal was normalized to a master control lysate. AZ-628 treatment reduced the level of phospho-MEK and phospho-ERK, but BAY61-3606 did not."
        ],
        "rois":[
          {
            "x":7,
            "y":1246,
            "x2":689,
            "y2":1789
          }
        ]
      }
    }
  },
  "278772":{
    "Figure_6.tif":{
      "a":{
        "descriptions":[
          "(a) Time course of phospho-I?????? (Ser32/Ser36) activation after 1 ??M AZ-628 treatment in HCT-116 (red lines) or HKe-3 (blue line) cells with MAP4K2 knock down, as measured via Bio-Plex. Relative signal was normalized to a master control lysate. Error bars represent SEM for 3 independent experiments. NF???? signaling was enhanced in HKe-3 cells after exposure to AZ-628 and this was dependent upon MAP4K2. "
        ],
        "rois":[
          {
            "x":7,
            "y":12,
            "x2":657,
            "y2":584
          }
        ]
      },
      "b":{
        "descriptions":[
          "(b) Cell viability quantified by Syto60 after 72 hours of combinatorial treatment with IKK inhibitor VII and 1 ??M AZ-628. Relative cell viability was normalized to DMSO vehicle treated control for each cell line. Like BAY61-3606, IKK inhibitor VII enhanced the effect of AZ-628 specifically in K-RAS wild-type cells. "
        ],
        "rois":[
          {
            "x":678,
            "y":7,
            "x2":1402,
            "y2":584
          }
        ]
      },
      "c":{
        "descriptions":[
          "(c) Cell viability after 72 hours of combinatorial treatment of 1 ??M IKK inhibitor VII and 1 ??M AZ-628 (shaded) or 1 ??M AZ-628 alone (clear) in HKe3 cells with MAP4K2 knockdown. Relative cell viability was normalized to 1 ??M AZ-628 treated samples. Loss of MAP4K2 abrogated the ability of IKK inhibitor VII to sensitize HKe-3 cells to AZ-628."
        ],
        "rois":[
          {
            "x":678,
            "y":7,
            "x2":1402,
            "y2":584
          }
        ]
      },
      "C":{
        "descriptions":[
          
        ],
        "rois":[
          {
            "x":1399,
            "y":9,
            "x2":2051,
            "y2":574
          }
        ]
      }
    }
  },
  "282492":{
    "Figure_5.tif":{
      "1":{
        "descriptions":[
          "(1) 5-kbp ladder (Bio-Rad) and "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1007,
            "y2":2463
          }
        ]
      },
      "2":{
        "descriptions":[
          "(2) supercoiled DNA ladder (Promega). The outer CD region probe is designed to detect the normal 16.5-kb circular mtDNA and the deleted 11.7-kb circular mtDNA, if the deletion is present. (B) Quantitative analysis of mtDNA lacking the 4977-bp region. The levels of mtDNA lacking the 4977-bp region were estimated from the ratio of the 11.7-kb circular mtDNA (indicated by arrow) to nuclear DNA (represented by ??-actin), and normalized to the value for control cells. Data are shown as the mean ?? standard error of the mean (SEM) from five independent measurements (n???=???5). Statistical significance of the difference as calculated by Student???s t-test is with p"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1007,
            "y2":2463
          }
        ]
      }
    }
  },
  "282577":{
    
  },
  "285099":{
    
  },
  "286582":{
    "Figure_1.tif":{
      "E":{
        "descriptions":[
          "(E) CD97 small isoforms in CD97/EGF1,2,5 knockdown group as compared with corresponding controls (*p"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3444,
            "y2":3152
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) CD97 expression on gastric carcinoma cell lines SGC-7901, AGS, BGC-823 and MGC-801. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3444,
            "y2":3152
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Expression of CD97 isoforms in SGCwt, SGC-NS and CD97/EGF1,2,5 knockdown groups. Semi-quantitative RT-PCR analysis, performed with the Bio 1D software, revealed differentially expressed "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3444,
            "y2":3152
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) CD97 small and "
        ],
        "rois":[
          
        ]
      },
      "D":{
        "descriptions":[
          "(D) big isoforms of the four cell lines, and significantly decreased levels of "
        ],
        "rois":[
          
        ]
      }
    }
  },
  "286774":{
    "Figure_2.tif":{
      "E":{
        "descriptions":[
          "(E) The biological activity of mouse recombinant chemerin was measured on mouse ChemR23-expressing CHO-K1 cells using the aequorin-based intracellular Ca2+ mobilization assay. Results are expressed as the percentage of the response to ATP and represent the mean ?? SD of duplicated data points. One representative experiment out of 3 is shown."
        ],
        "rois":[
          {
            "x":113,
            "y":1295,
            "x2":847,
            "y2":1899
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) Peritoneal macrophages from WT or ChemR23???/??? mice, collected following i.p. Bio-Gel injection, were stimulated for 15 h by 100 ng/ml LPS or left unstimulated. Cells were harvested, and expression of ChemR23 was determined by quantitative RT-PCR. Data are expressed as mean ?? SEM for 3 independent experiments performed in duplicate. "
        ],
        "rois":[
          {
            "x":941,
            "y":1300,
            "x2":1674,
            "y2":1904
          },
          {
            "x":8,
            "y":7,
            "x2":530,
            "y2":719
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Peritoneal cells from WT or ChemR23???/??? mice, collected following i.p. Bio-Gel injection, were analysed by flow cytometry, directly or after selection by adherence to plates. Cells were stained for leukocyte markers (F4-80 and Gr1) and expression of ChemR23 on F4-80+ Gr1??? (M??) and F4-80??? Gr1+ (PMN) cells was evaluated using flow cytometry. Histograms represent the fluorescence observed following ChemR23 staining on peritoneal cells from WT (black histogram) or ChemR23???/??? (white histogram) mice, compared to the isotype-matched control (dotted line). One representative experiment out of 3 is shown. "
        ],
        "rois":[
          {
            "x":590,
            "y":7,
            "x2":1371,
            "y2":742
          },
          {
            "x":1396,
            "y":59,
            "x2":1901,
            "y2":715
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Total peritoneal cells from WT and ChemR23???/??? mice, collected following i.p. Bio-Gel injection, were incubated with increasing concentrations of radiolabeled chemerin (???). Non-specific binding was determined in the presence of a 100-fold excess of unlabeled chemerin (*), and specific binding (???) was calculated as the difference. One representative experiment out of 3 is shown. "
        ],
        "rois":[
          {
            "x":10,
            "y":729,
            "x2":579,
            "y2":1280
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) Peritoneal macrophages from WT or ChemR23???/??? mice, collected following i.p. Bio-Gel injection, were tested for their ability to migrate in response to recombinant mouse chemerin. In the left panel (mean ?? SEM for 3 independent experiments performed in quadruplicate), the whole populations of cells recovered was used. In the right panel (mean ?? SD for an experiment performed in triplicate), macrophages selected by overnight adherence were used. Results are expressed as migration index. "
        ],
        "rois":[
          {
            "x":14,
            "y":1957,
            "x2":1760,
            "y2":2611
          },
          {
            "x":699,
            "y":734,
            "x2":1216,
            "y2":1218
          },
          {
            "x":1378,
            "y":727,
            "x2":1895,
            "y2":1218
          }
        ]
      }
    }
  },
  "286931":{
    
  },
  "287066":{
    
  },
  "288622":{
    
  },
  "291286":{
    "Figure_10.tif":{
      "1":{
        "descriptions":[
          ". 1) While the spatial statistical (SS) model identified 6 disease clusters (the 6 epidemic nodes, of which two partially overlapped, which are seen, within the red pentagon, as 4 circles or ovals, of different colors), because the SS approach does not offer information on directionality, control measures should consider every epidemic node, i.e., the overall ???cost??? of an intervention would be equal to the sum of the areas of the 6 original epidemic nodes included in the red pentagon"
        ],
        "rois":[
          {
            "x":20,
            "y":29,
            "x2":3407,
            "y2":4310
          }
        ]
      },
      "2":{
        "descriptions":[
          ". 2) If a Network Theory (NT) perspective were considered, only a single cluster would be observed (the area included within the red pentagon, which is defined by nodes and edges [road segments]). The NT model may generate several cost-benefit metrics"
        ],
        "rois":[
          {
            "x":20,
            "y":29,
            "x2":3407,
            "y2":4310
          }
        ]
      },
      "3":{
        "descriptions":[
          ". 3) A bio-geo-temporal analysis can integrate both SS advantages (a small area) and NT advantages (identification of the most influential node, based on analysis of network properties). The bio-geo-temporal model can generate the lowest ???cost??? (smallest area to be intervened per each prevented case). Calculations are reported in the text."
        ],
        "rois":[
          {
            "x":20,
            "y":29,
            "x2":3407,
            "y2":4310
          }
        ]
      }
    }
  },
  "29207":{
    
  },
  "29208":{
    
  },
  "294217":{
    "Figure_4.tif":{
      "C":{
        "descriptions":[
          "(C) but not PP cells "
        ],
        "rois":[
          {
            "x":14,
            "y":14,
            "x2":1789,
            "y2":674
          },
          {
            "x":14,
            "y":682,
            "x2":896,
            "y2":1455
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D). "
        ],
        "rois":[
          {
            "x":842,
            "y":1443,
            "x2":1325,
            "y2":2813
          },
          {
            "x":25,
            "y":1443,
            "x2":829,
            "y2":2812
          },
          {
            "x":904,
            "y":682,
            "x2":1788,
            "y2":2813
          }
        ]
      },
      "E":{
        "descriptions":[
          "(E) Immunoblot profiles showing that anti-PP and anti-PRT antibodies specifically recognize parapinopsin and parietopsin expressed in cultured cells. Monoclonal antibody rho 1D4 stains iguana parapinopsin (arrowhead) and parietopsin (asterisk) tagged with rho 1D4 epitope, in SDS-extracts form PP and PRT cells (lanes 3 and 4) but not from mock transfected cells (lane 2). Anti-PP specifically stained ???38 k peptide (lane 6, arrowhead), which is the same as the band stained by rho 1D4 (lane 3), in PP cells but not in mock cells (lane 5) or PRT cells (lane 7). Anti-PRT antibodies recognize specifically ???39 k peptide (lane 10, asterisk), which is identical to the stained band by rho 1D4 (lane 4) in PRT cells, but not in mock cells (lane 8) or PP cells (lane 9). M indicates Molecular weight standard markers (lane 1) (Bio-Rad Laboratories)."
        ],
        "rois":[
          {
            "x":14,
            "y":682,
            "x2":896,
            "y2":1455
          }
        ]
      }
    }
  },
  "296301":{
    "Figure_3.tif":{
      "A":{
        "descriptions":[
          "(A) and ??-galactosidase activity ",
          "(A) A small amount of RraA protein expressed from the lacZ promoter of the pTrc-rraA plasmid was sufficient to suppress the SOS response; the level mediating such suppression was compared to the level of RraA protein expressed in stationary phase (after 24 h growth) by untreated SY2 cells harboring pTrc-99A (empty plasmid). Aliquots were assayed by Western blot at various times with and without MTC addition (samples were separated by Criterion 12% Bis-Tris gel electrophoresis using XT-MOPS buffer and were immunoblotted using anti-RraA and anti-S1 antibodies. Specific protein bands were imaged by VersaDoc 1000 (Bio-Rad) and quantified by Quantity One (Bio-Rad). "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1972,
            "y2":2127
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B). ",
          "(B) Repression of SOS response by leaky expression of RraA from pTrc-rraA plasmid in SY2 cells cultured in the absence of IPTG. SOS response was induced at 0 time in SY2 cells harboring pTrc99A (???, empty plasmid) or pTrc-rraA (???) by addition of MTC (0.1 ??g/ml)."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1972,
            "y2":2127
          }
        ]
      }
    }
  },
  "298122":{
    
  },
  "298511":{
    
  },
  "299285":{
    "Figure_3.tif":{
      "A":{
        "descriptions":[
          "A. Fluorogenic assay. RT activity was measured by detection of RNA:DNA heteroduplex by fluorescence of EvaGreen binding. Oligo dT primed poly A was incubated at 37??C and 65??C in the presence of indicated Pol enzymes in manufacturer recommended buffers and dTTP. Fluorescence measurements were obtained every 6 seconds for 10 minutes. The initial slopes from a plot of RFU vs. time in seconds were determined by linear least square regression from 30 to 150 seconds at 37??C and from 30 to 90 seconds at 65??C. Error bars are standard error of regression slope"
        ],
        "rois":[
          {
            "x":144,
            "y":1749,
            "x2":661,
            "y2":2743
          },
          {
            "x":8,
            "y":8,
            "x2":878,
            "y2":773
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B. RT primer extension assay. HEX-labeled dT20 primed poly A was incubated 10 minutes at 37??C and then 10 minutes at 65??C in the presence of indicated Pol enzymes and dTTP in manufacturer recommended buffers. Primer extension products were resolved by 10% denaturing PAGE and imaged on a Molecular Imager FX (Bio-Rad). Left facing triangle indicates migration of unextended dT20 primer and asterisk indicates bromophenol blue dye front"
        ],
        "rois":[
          {
            "x":12,
            "y":784,
            "x2":873,
            "y2":1750
          }
        ]
      },
      "C":{
        "descriptions":[
          ". C. RT MS2-specific primer extension. 5???-labeled primer was annealed to MS2 RNA and incubated 10 minutes at 37??C and then 30 minutes at 65??C in the presence of indicated Pol enzymes with dNTPS (N???=???A,C,G,T) in manufacturer recommended buffers. Primer extension products were resolved by 5% denaturing PAGE. Lane 1 No RNA+MMLV RT; Lane 2: MS2 RNA No RT; Lane 3 MS2 RNA+MMLV RT, Lane 3 MS2 RNA+3173 Pol. Molecular weight in bases indicted. Red Arrow: ???650 base MMLV extension product. Blue Arrow: ???715 base PyroScript extension product. Green arrow: Non-templated MMLV reaction product."
        ],
        "rois":[
          {
            "x":12,
            "y":784,
            "x2":873,
            "y2":1750
          }
        ]
      }
    }
  },
  "30038":{
    
  },
  "30040":{
    
  },
  "30041":{
    
  },
  "300693":{
    "Figure_4.tif":{
      "E":{
        "descriptions":[
          "(E) Primers specific for the overlapping regions bb0685-bb0686 (5 and 8), bb0686-bb0687 (7 and 10) and bb0687-bb0688 (9 and 12) amplified genomic DNA (lane 4) but not cDNA (lane 3), indicating that the ORFs are not co-transcribed The images were generated using the Versadoc imaging system (Bio-Rad Laboratories, Hercules"
        ],
        "rois":[
          {
            "x":802,
            "y":862,
            "x2":2086,
            "y2":1351
          },
          {
            "x":23,
            "y":848,
            "x2":852,
            "y2":1339
          },
          {
            "x":11,
            "y":11,
            "x2":2024,
            "y2":210
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) Schematic representation of the borrelial mevalonate pathway that extends from bb0683 to bb0688. The arrows with numbers refer to primers used for the RT-PCR amplicons (depicted in B-E) separated on a 1% agarose gel stained with ethidium bromide. (B-E) The templates used in PCR amplification (B-E) are from B. burgdorferi strain B31 clonal isolate MSK5 and are as follows: Lane 1, PCR master mix with no template (double-distilled H2O control); Lane 2, total RNA (-RT control); Lane 3, cDNA (+RT); Lane 4, total genomic DNA. Lanes M and M2, molecular size markers in kilobases "
        ],
        "rois":[
          
        ]
      },
      "M":{
        "descriptions":[
          "(M) or base pairs (M2) as indicated on the left and right sides, respectively. "
        ],
        "rois":[
          {
            "x":802,
            "y":862,
            "x2":2086,
            "y2":1351
          },
          {
            "x":23,
            "y":293,
            "x2":770,
            "y2":791
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Primers specific for bb0683 (1 and 2) and bb0684 (3 and 4) amplified cDNA (lane 3) and genomic DNA (lane 4). "
        ],
        "rois":[
          {
            "x":11,
            "y":11,
            "x2":2024,
            "y2":210
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Primers specific for bb0685 (5 and 6), bb0686 (7 and 8), bb0687 (9 and 10) and bb0688 (11 and 12) amplified cDNA (lane 3), and genomic DNA (lane 4) indicating active transcription of these ORFs. "
        ],
        "rois":[
          {
            "x":11,
            "y":11,
            "x2":2024,
            "y2":210
          },
          {
            "x":804,
            "y":298,
            "x2":2087,
            "y2":786
          }
        ]
      },
      "CA":{
        "descriptions":[
          ", CA)."
        ],
        "rois":[
          
        ]
      },
      "D":{
        "descriptions":[
          "(D) Primers specific for the overlapping regions bb0683-bb0684 (1 and 4), bb0684-bb0685 (3 and 6) amplified genomic DNA (lane 4), but not cDNA (lane 3) indicating that the ORFs are not co-transcribed. "
        ],
        "rois":[
          {
            "x":802,
            "y":862,
            "x2":2086,
            "y2":1351
          },
          {
            "x":11,
            "y":11,
            "x2":2024,
            "y2":210
          }
        ]
      }
    }
  },
  "302232":{
    
  },
  "3024061":{
    
  },
  "3024370":{
    "Fig 2.tif":{
      "A":{
        "descriptions":[
          "A. Relative abundance of five genera, which were the most abundant among those that changed during time"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3899,
            "y2":1911
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B. Akkermansia abundance"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3899,
            "y2":1911
          }
        ]
      },
      "C":{
        "descriptions":[
          ". C. Relative abundance of all KEGG pathways that changed during whole study",
          ", C: over the six time points), or the Wilcoxon test (B"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3899,
            "y2":1911
          }
        ]
      },
      "D":{
        "descriptions":[
          ". D. Metabolic pathways that changed from baseline to T3. Abbreviations: bios, biosynthesis; met, metabolism. Statistics: Relative abundances are expressed in percent (abundance at T0 is 100%). Each dot is the mean at a given time point. Relative abundances at different time points were compared using the Friedman test (A",
          ", D, *p "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3899,
            "y2":1911
          }
        ]
      }
    }
  },
  "3024412":{
    "Fig 3.tif":{
      "A":{
        "descriptions":[
          "(A). The binding protein was analyzed by MALDI-TOF MS after in-gel digestion, and found to be eEF1A2 "
        ],
        "rois":[
          {
            "x":4,
            "y":4,
            "x2":590,
            "y2":597
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B). Western blotting with anti-eEF1A2 antibody confirmed the identity of the binding protein "
        ],
        "rois":[
          {
            "x":714,
            "y":5,
            "x2":1916,
            "y2":980
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C). Confocal microscopy revealed co-localization of FITC-labeled MLIF (green) and eEF1A2 (labeled with rabbit anti-eEF1A2; red) in SH-SY5Y cells "
        ],
        "rois":[
          {
            "x":9,
            "y":1106,
            "x2":1108,
            "y2":1480
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D)."
        ],
        "rois":[
          {
            "x":9,
            "y":1106,
            "x2":1108,
            "y2":1480
          },
          {
            "x":1109,
            "y":1177,
            "x2":1968,
            "y2":1480
          }
        ]
      }
    }
  },
  "3024718":{
    "Fig 6.tif":{
      "A":{
        "descriptions":[
          "A: Bio 1 (annual mean temperature)"
        ],
        "rois":[
          {
            "x":1151,
            "y":46,
            "x2":2246,
            "y2":960
          }
        ]
      },
      "B":{
        "descriptions":[
          ", B: Bio 2 (precipitation of seasonality (coefficient of variation)"
        ],
        "rois":[
          {
            "x":1152,
            "y":1107,
            "x2":2264,
            "y2":2011
          },
          {
            "x":9,
            "y":11,
            "x2":1143,
            "y2":948
          }
        ]
      },
      "C":{
        "descriptions":[
          ", C: Bio 16 (Precipitation of Wettest Quarter)"
        ],
        "rois":[
          {
            "x":15,
            "y":1059,
            "x2":1141,
            "y2":2010
          },
          {
            "x":1152,
            "y":1107,
            "x2":2264,
            "y2":2011
          }
        ]
      },
      "D":{
        "descriptions":[
          ", D: Bio 19 (Precipitation of Coldest Quarter). Populations in the northern region represented by open circles and in the southern region represented by red circles."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "304574":{
    "Figure_4.tif":{
      "a":{
        "descriptions":[
          "(a) Detection of DSBs by PFGE. After 10 Gy IR exposure CCDC6-depleted (shCCDC6) and CCDC6-proficient (shCTRL) HeLa cells have been collected at different time points (1, 2, 4, 24 hours). Densitometric analysis of DSBs bands were plotted as percentage of total DNA. "
        ],
        "rois":[
          
        ]
      },
      "b":{
        "descriptions":[
          "(b) The percentages of GFP positive cells, compared to controls, have been plotted on the histograms that are representative of three independent experiments. Error bars indicate the standard error mean. The anti-HA-I-Sce1 and anti-tubulin immunoblots are shown at bottom of the figure. "
        ],
        "rois":[
          
        ]
      },
      "c":{
        "descriptions":[
          "(c) HeLa cells, bearing the doxycycline-inducible I-Sce1 DNA repair construct, have been transfected with control shRNAs (shCTRL) or sh-CCDC6 by Microporator MP-100 transfection system (Digital Bio, Korea). The CCDC6 protein depletion was assessed by western blot analysis for every rate of transfection (#1, #2, #3, #4). The percentages of protein expression, compared to controls, have been plotted on the histogram below."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3031,
            "y2":3216
          }
        ]
      }
    }
  },
  "304891":{
    
  },
  "307446":{
    "Figure_7.tif":{
      "A":{
        "descriptions":[
          "(A)"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1704,
            "y2":1408
          }
        ]
      },
      "B":{
        "descriptions":[
          " Cells were exposed to Ad.TERT.LacZ (10 MOI), Ad.TERT.T??10 (10 MOI), and actin polymerization inhibitor (cytochalasin D, 1 ??g/ml) for 48 hr, and then a mitochondrial membrane potential (MMP) assay was performed. The MMP assay was performed using the MMP assay kit protocol (Thermo), and the results were imaged using a Thermo Scientific Cellomics ArrayScan high-content screening (HCS) reader. (B)"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1704,
            "y2":1408
          },
          {
            "x":0,
            "y":1409,
            "x2":1704,
            "y2":1778
          }
        ]
      },
      "P":{
        "descriptions":[
          " Cells were exposed to Ad.TERT.LacZ (10 MOI), Ad.TERT.T??10 (10 MOI) with or without anti-cancer agents, such as paclitaxel (taxol, 5 ??g/ml) and cisplatin (platinum, 10 ??g/ml), for 48 hr. The results were compared to those from other treatments, for example, each anti-cancer agent or actin polymerization inhibitor (cytochalasin D, 1 ??g/ml). The levels of intracellular reactive oxygen species (ROS) were detected by a fluorescence ELISA system with the oxidation-sensitive fluorescent probe 2, 7-dichlorofluorescein diacetate (DCF-DA). In addition to the ROS assay, an MTT-bio assay was also performed under the same conditions. The all results are expressed as a percentage of the vehicle control and are mean ?? SE (bars) of three experiments.??Significant differences from vehicle control group are denoted by an asterisk (*), P"
        ],
        "rois":[
          
        ]
      }
    }
  },
  "3078787":{
    "Fig 3.tif":{
      "a":{
        "descriptions":[
          "(a) Switch off in C3 and D2 on LD2 and LD4 respectively; Hypothesis of partial switch on when regulatory region of LD2 is absent, as evidenced in C2. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2325,
            "y2":1219
          }
        ]
      },
      "b":{
        "descriptions":[
          "(b) Concentration calibration curves depicting binding of constructs B2, C35, ???54???189???, ???79???189???, ???105???189??? with GST-FAT. The data is representative of a single experiment. Each experiment was performed at-least thrice. "
        ],
        "rois":[
          {
            "x":0,
            "y":1220,
            "x2":878,
            "y2":1623
          },
          {
            "x":0,
            "y":0,
            "x2":2325,
            "y2":1219
          }
        ]
      },
      "c":{
        "descriptions":[
          "(c) Illustrations of C35, C35_1, C35_2 and C35_3."
        ],
        "rois":[
          {
            "x":879,
            "y":1220,
            "x2":1193,
            "y2":1623
          }
        ]
      },
      "C":{
        "descriptions":[
          
        ],
        "rois":[
          {
            "x":1194,
            "y":1220,
            "x2":2325,
            "y2":1623
          },
          {
            "x":0,
            "y":1624,
            "x2":2325,
            "y2":3199
          }
        ]
      }
    }
  },
  "3080182":{
    
  }
}
